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Background: Despite growing calls for the provision of ancillary care 
to study participants during medical research, there remains a 
noticeable gap in ethical guidelines for medical researchers in 
resource-constrained settings (RCS). We reviewed recent studies to 
determine the extent to which ancillary care is provided in East and 
Southern Africa and to examine the ethical justifications researchers 
provide to support their views on ancillary care obligations. 
Methods: A systematic search for qualitative and mixed methods 
studies on ancillary care was conducted across MEDLINE, Embase, 
African Wide Information, PubMed, CINAHL Plus, and Scopus. The 
National Institutes of Health (NIH) Department of Bioethics and H3 
Africa websites and Google Scholar were further searched. Studies 
conducted in East and Southern Africa between 2004 and 2020, as well 
as those that reported on ancillary care provided to study participants 
were included. All studies included in this review were evaluated for 
methodological quality as well as bias risk. NVivo version 12 was used 
for thematic analysis. 
Results: Overall, 4,710 articles were identified by the initial search. 
After the data extraction and quality assessment, 24 articles were 
included. Key areas presented include ancillary care approaches and 
the themes of researcher motivation for providing ancillary care and 
expectations of participants in medical research. The review shows 
that while some international researchers do provide ancillary care to 
their study participants, approaches are not standardised without 
consistent guidelines for ethical practice for ancillary care. We found 
limited empirical studies in RCS that report on ancillary care, hence 
findings in this review are based on single studies rather than a 
collection of multiple studies. 
Conclusions: This paper emphasizes the value of establishing ethics 
guidelines for medical researchers in RCS who consider provision of 
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ancillary care to their participants, and the need to account for these 
ethical guidelines in medical research.
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Introduction
Providing care and support to study participants during medi-
cal research that is not in pursuit of the research scientific objec-
tives, to prevent study-related harms, or address study-related 
injuries presents ethical challenges worldwide1. There remains 
a noticeable gap in research guidelines addressing medical 
researchers’ obligations to provide additional or ancillary care 
in resource-constrained settings (RCS). Without clear guid-
ance, how can and do researchers navigate and respond to the 
broader needs of ancillary care in RCS? The ethical impera-
tive for provision of ancillary care during medical research has 
been documented and recommendations for the provision of 
such care are incorporated in ethical guidance such as the 
Council for International Organizations of Medical Sciences 
(CIOMS) in collaboration with the World Health Organization 
(WHO) and the Nuffield Council on Bioethics. These respectively 
state:
	 	“when	 participants’	 health	 needs	 during	 and	 after	
research	 cannot	 be	 met	 by	 local	 health	 infrastruc-
ture	 or	 the	 participant’s	 pre-existing	 health	 insur-
ance,	 the	 researcher	 and	 sponsor	 must	 make	 prior	
arrangement	 for	 adequate	 care	 for	 participants	 with	
local	 health	 authorities,	 members	 of	 the	 communities	
from	 which	 persons	 are	 drawn,	 or	 nongovernmental	
organisations	such	as	health	advocacy	groups”2.
	 	“…during	 research,	 participants	 may	 develop	 an	
entirely	 unrelated	 condition.	 In	 some	 circumstances,	
it	 may	 be	 relatively	 easy	 for	 researchers	 to	 treat	 the	
condition	 or	 refer	 participants	 to	 a	 local	 health	 centre	
where	treatment	can	be	provided”3.
Despite the existence of such guidance and extensive 
discussion in the ethics literature4, how this care can be achieved 
in practice, particularly across populations that vary politi-
cally, socially, and culturally is a matter for debate. This debate 
is heightened in RCS, where individuals who volunteer to 
participate in research may have several unmet health needs. 
Participants in low- and middle-income countries (LMICs) 
often live in poverty, suffer disproportionately from high dis-
ease burdens, such as HIV, tuberculosis, and malaria, and are 
often limited to sub-standard health care systems5. Even while 
health care services can be available within the local health 
care system, people are concerned about such services because 
of quality and costs6,7. Existing limitations in accessibility 
and affordability of health care services are compounded by 
ongoing structural inequalities in health access, education, and 
socioeconomic status, leading to poor health outcomes. These 
underlying and overlapping structural issues may influence 
research participation amongst those most in need in order 
for them to access effective health care provided as a compo-
nent of research. Recognising these structural concerns in RCS, 
researchers encounter a variety of unmet health needs among 
their research participants, many of whom will require medi-
cal care ancillary to the study8. For example, a study on malaria 
may uncover other comorbidities like HIV or other infec-
tious disease other than the condition under study. Despite 
recognition that additional health needs commonly arise 
amongst research participants, there is a lack of evidence 
as to how researchers actually respond when conducting 
research in RCS as well as questions as to their obligations to 
provide such care.
There is some evidence regarding the ethics of ancillary care 
in research conducted in developing countries4,9,10. Some 
recent studies have reported on the obligations of medical 
researchers to provide ancillary care to their participants11–13. 
While recognising these ethical obligations of ancillary care 
in medical research, researchers have argued that provision 
of ancillary care could unduly influence4,14,15 or could be a 
form of structural coercion to participants16–18 and also as one 
way of exploitation of vulnerable populations19–21. The chal-
lenge, however, is that while much research has been con-
ducted on the ethics of ancillary care in the context of medical 
research, there is a lack of clarity of what ancillary care means 
and the concept remains insufficiently unpacked to guide medi-
cal research in RCS. Our focus in this paper is on this paucity 
of information on approaches to and applications of ancillary 
care provision in East and Southern Africa.
Using a mixed methods approach, including systematic review 
and meta-synthesis, we looked for evidence of information 
on ancillary care provision or provision of care to study 
participants during research. We carried out a review of stud-
ies conducted in East and Southern Africa, where structural ine-
qualities are particularly salient, that reported some ancillary 
care or the need to provide ancillary care to study participants. 
We seek to answer the question: “what are the current practices 
of and factors that influence the provision of ancillary care dur-
ing medical research in east and southern Africa?” Specifically, 
we aimed to ascertain the current evidence on the extent of pro-
vision of ancillary care in East and Southern Africa and to 
explore the ethical justifications researchers provide to support 
their views on ancillary care obligations. 
Methods
A systematic search was conducted to synthesise published 
articles and researchers that have recently worked on medical 
research that involved the provision of care and support to 
study participants in East and Southern Africa were contacted 
in an attempt to obtain their published articles if not available 
online. This review included qualitative empirical studies, 
systematic reviews, and theoretical articles describing the 
ethics of ancillary care. The Preferred Reporting Items for 
Systematic Reviews and Meta-analyses (PRISMA)22,23 guide-
lines were followed. Since this study utilised a secondary syn-
thesis of data, which is already in the public domain, ethical 
approvals, and consent to participate were not necessary.
Search strategy
A comprehensive electronic search strategy was conducted 
to identify all relevant published studies where the primary 
focus was to highlight the provision of care to study participants 
by medical researchers, the variety of forms of care provided, 
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and the ethical basis justifying care provision. The search cov-
ered the period between June 2004 and November 2020 to 
ensure that the studies’ findings reflected the role of ancillary 
care in medical research established in 20041 and reflect key 
information pertaining to current practices of ancillary care in 
RCS. Six databases were searched in November 2020. The ini-
tial search was conducted using a combination of index terms 
and text-based queries in Ovid MEDLINE. We used this as 
a primary search strategy to identify text words contained in 
the title and abstract as well as classify the appropriate MeSH 
terms to be used (Table 1).
The next step used identified keywords and index terms in five 
electronic databases: Embase via Ovid® host, African Wide 
Information via EBSCO host, PubMed, CINAHL Plus, and 
Scopus, Table 2. A search string involving relevant key words 
and possible variations was constructed based on the domain 
(medical and behavioural research in RCS) and practices (provi-
sion of ancillary care to study participants). The search strat-
egy was readjusted several times for comprehensive and updated 
retrieval. The National Institutes of Health (NIH) Department 
of Bioethics, Human Heredity and Health in Africa (H3 Africa) 
and Google Scholar websites were added to the search. The 
reference lists of all studies potentially eligible for inclusion 
were screened to elicit additional relevant articles. If the full-text 
article was not available online, one attempt was made to con-
tact the author, and if no response was received the article was 
excluded.
Study selection and eligibility criteria
The database search was initially conducted against a broad 
inclusion criterion by the first reviewer (BK) and was focused 
on the title and abstract of the articles. All articles identified to 
be potentially eligible for inclusion in this study were obtained 
in full texts. BK then conducted full-text article screening 
to identify studies that met the following inclusion criteria:
•      Qualitative empirical study, systematic review or theoretical 
article
•						Published	between	June	2004	and	November	2020
•						Related	 to	 the	 domain	 of	 medical	 research	 involving	
human	subjects	conducted	in	East	and	Southern	Africa
•						Providing	 narratives	 on	 the	 ethics	 of	 ancillary	 care	
provision	and	experiences	in	RCS
Table 1. Systematic review MEDLINE full search strategy.
Database: Ovid MEDLINE(R) and Epub Ahead of Print, In-Process & Other Non-Indexed Citations, Daily and Versions(R) 

















exp “Delivery of Health Care”/ 
(additional adj5 care).mp. 
(additional adj5 service*).mp. 
(additional adj5 practice*).mp. 
Ancillary Care, Research/
















treat*.mp. [mp=title, abstract, original title, name of substance word, subject heading word, floating sub-heading word, keyword 
heading word, organism supplementary concept word, protocol supplementary concept word, rare disease supplementary 
concept word, unique identifier, synonyms] 
 
(referral* or refer or referred).mp. [mp=title, abstract, original title, name of substance word, subject heading word, floating 
sub-heading word, keyword heading word, organism supplementary concept word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier, synonyms] 
 
“Referral and Consultation”/ 
 
(consulted or consultation* or consult?).mp. [mp=title, abstract, original title, name of substance word, subject heading word, 
floating sub-heading word, keyword heading word, organism supplementary concept word, protocol supplementary concept 
word, rare disease supplementary concept word, unique identifier, synonyms] 
 
insurance. mp. [mp=title, abstract, original title, name of substance word, subject heading word, floating sub-heading 
word, keyword heading word, organism supplementary concept word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms]
Page 4 of 20
Wellcome Open Research 2021, 6:164 Last updated: 08 JUL 2021
























ethic*.mp. [mp=title, abstract, original title, name of substance word, subject heading word, floating sub-heading word, keyword 
heading word, organism supplementary concept word, protocol supplementary concept word, rare disease supplementary 




moral*.mp. [mp=title, abstract, original title, name of substance word, subject heading word, floating sub-heading word, keyword 
heading word, organism supplementary concept word, protocol supplementary concept word, rare disease supplementary 
concept word, unique identifier, synonyms] 
 
social.mp. [mp=title, abstract, original title, name of substance word, subject heading word, floating sub-heading word, keyword 
heading word, organism supplementary concept word, protocol supplementary concept word, rare disease supplementary 
concept word, unique identifier, synonyms] 
 
obligation*.mp [mp=title, abstract, original title, name of substance word, subject heading word, floating sub-heading 
word, keyword heading word, organism supplementary concept word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
 
responsib*.mp [mp=title, abstract, original title, name of substance word, subject heading word, floating sub-heading 
word, keyword heading word, organism supplementary concept word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
 
dut*.mp [mp=title, abstract, original title, name of substance word, subject heading word, floating sub-heading word, keyword 
heading word, organism supplementary concept word, protocol supplementary concept word, rare disease supplementary 
concept word, unique identifier, synonyms]














(medical or health-related or biomedical).mp. [mp=title, abstract, original title, name of substance word, subject heading word, 
floating sub-heading word, keyword heading word, organism supplementary concept word, protocol supplementary concept 
word, rare disease supplementary concept word, unique identifier, synonyms] 
 
(behavioral or social).mp. [mp=title, abstract, original title, name of substance word, subject heading word, floating sub-heading 
word, keyword heading word, organism supplementary concept word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
 
researche*,mp. [mp=title, abstract, original title, name of substance word, subject heading word, floating sub-heading 
word, keyword heading word, organism supplementary concept word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
 
(clinical trials or observation* studies or cohort studies).mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, floating sub-heading word, keyword heading word, organism supplementary concept word, protocol 
supplementary concept word, rare disease supplementary concept word, unique identifier, synonyms]


























south africa*.mp. [mp=title, abstract, original title, name of substance word, subject heading word, floating sub-heading 
word, keyword heading word, organism supplementary concept word, protocol supplementary concept word, rare disease 




malawi*.mp. [mp=title, abstract, original title, name of substance word, subject heading word, floating sub-heading word, keyword 
heading word, organism supplementary concept word, protocol supplementary concept word, rare disease supplementary 




east* africa*.mp. [mp=title, abstract, original title, name of substance word, subject heading word, floating sub-heading 
word, keyword heading word, organism supplementary concept word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
 
exp Africa, Eastern/ 
 
exp Africa, Southern/ 
 
southern africa*.mp. [mp=title, abstract, original title, name of substance word, subject heading word, floating sub-heading 
word, keyword heading word, organism supplementary concept word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms]
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•						Reporting	 ancillary	 care	 practices,	 including	 the	 provi-
sion	 of	 standard	 of	 care	 to	 research	 participants	 additional	
to	 study	 related	 care.	 Clinical	 trials,	 observational	 studies,	
and	 prospective	 cohort	 studies	 that	 report	 on	 provision	
of	 ancillary	 care	 as	 part	 of	 the	 trial,	 either	 formally	 or	
informally	were	eligible.
Studies were excluded if they were published prior to 2004 
and not in English; if they documented or reported provi-
sion of care or support to study participants as part of the study; 
if conducted in high-resource settings; if they were opinion 
or commentary papers and workshop or meeting reports; and 
if there was no clear statement on the study setting. 
Quality appraisal
Methodological rigor was achieved through three independ-
ent reviewers (BK, ND and JS) critically appraising the meth-
odological quality of the included studies. All potentially 
eligible studies were appraised and scored for methodological 
quality according to the Joanna Briggs Institute critical appraisal 
checklist for qualitative studies (JBI-QARI)24,25. Compared 
to other commonly used tools, the domains examined in this tool 
have been found to be more coherent and sensitive to assess-
ment of quality, Table 3. The quality assessment was used not as 
a basis to exclude studies but rather to: (1) ascertain the relative 
contribution of each study to the overall synthesis and (2) assess 
the methodological rigour of each study as part of a proc-
ess of assessing confidence in the review findings as well as to 
assess risk of bias26,27.
The JBI-QARI 10 questions were applied to each individual 
paper and an aggregate score was calculated (Table 4). For 
systematic reviews and theoretical studies, we applied the 
AMSTAR 2 (a measurement tool to assess systematic reviews)28 
checklist based on the 16 items (Table 5 and Table 6).
Any disagreements that arose between reviewers were resolved 
through discussion with at least one other member of the 
research team. Team meetings were used to achieve a shared 
and consistent approach in operationalising the domains in the 
tools and inclusion of studies.
Data extraction
Details of each of the included papers were imported into a 
2016 Microsoft Excel® (Microsoft Corporation, Redmond, 
WA, USA) file and duplicate articles were removed. Data extrac-
tion of study characteristics was primarily undertaken by one 
reviewer (BK); however, a second and third reviewer (ND 
and JS) randomly selected papers and double-checked the 
extractions for accuracy. In addition, the team had regular meet-
ings to discuss any uncertainties, to ensure consistency of 
the approach and to agree definitions.
Portable Document Format files of all the included papers were 
then imported into NVivo 12 (QSR International, Warrington, 
UK) software and the “methods and results” sections were 
coded and analysed. If relevant information was located in other 
parts of the papers (for example, the background or discus-
sion sections), these were also coded. Each relevant full-text 
Table 2. Summary of the search strategy used for the review.
1. Type of literature Source 
a Published materials MEDLINE
EMBASE




b Grey Literature Google Scholar
NIH – the department of Bioethics
H3 Africa
2. Search Terms  
ancillary OR additional AND care OR treatment OR services
obligation OR responsibilities OR duties AND researcher
behavioural OR medical OR health related AND research OR studies
LMIC OR sub-Saharan Africa OR southern Africa OR east Africa OR Malawi
ethics 
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Table 3. Critical appraisal checklist for qualitative studies. Y=yes, N=no, U=unclear/unsure, P=partially.
Question Y N U P
1. Is there congruity between the stated philosophical perspective and the research methodology? ☐ ☐ ☐ ☐
2. Is there congruity between the research methodology and the research question or objectives? ☐ ☐ ☐ ☐
3. Is there congruity between the research methodology and the methods used to collect data? ☐ ☐ ☐ ☐
4. Is there congruity between the research methodology and the representation and analysis of data? ☐ ☐ ☐ ☐
5. Is there congruity between the research methodology and the interpretation of results? ☐ ☐ ☐ ☐
6. Is there a statement locating the researcher culturally or theoretically? ☐ ☐ ☐ ☐
7. Is the influence of the researcher on the research, and vice- versa, addressed? ☐ ☐ ☐ ☐
8. Are participants, and their voices, adequately represented? ☐ ☐ ☐ ☐
9. Is the research ethical according to current criteria or, for recent studies, and is there evidence of ethical 
approval by an appropriate body?
☐ ☐ ☐ ☐
10. Do the conclusions drawn in the research report flow from the analysis, or interpretation, of the data? ☐ ☐ ☐ ☐
Table 4. JB-QARI quality assessment score.









or low1 2 3 4 5 6 7 8 9 10
Barsdorf et al., 2010 Y Y Y Y Y N P Y Y Y 8.5 high thick journal high
Chou et al., 2007 Y Y Y Y Y P Y U U P 8 high thick journal high
Devries et al., 2015 Y U Y U Y N Y U Y N 7 high thick journal high
Essack et al., 2010 Y P Y N U P U U Y N 5.5 low thin journal low
Gooding et al., 2018 Y Y P U U Y N Y P N 6 medium thick journal medium
Kamuya et al., 2013 Y P Y Y Y P Y U Y P 8 high thick journal high
Kamuya et al., 2014 Y N Y P P Y P Y Y U 7 high thick journal high
Lairumbi et al., 2012 Y Y Y N Y N Y N Y N 6 medium thick journal medium
Mfutso-Bengo et al., 
2008
Y Y Y U Y P P U Y N 7 high thick journal high
Mfutso-Bengo et al., 
2015
Y Y Y Y P U U U Y N 7.5 high thick journal medium
Mtunthama et al., 2008 Y P Y Y Y P Y U Y P 8 high thick journal high
Nkosi et al., 2020 Y Y Y Y Y Y U U Y P 8.5 high thick journal high
Pratt and Hyder, 2018 Y Y Y P P Y P U N N 6 medium thin journal low
Ramjee et al., 2010 Y U Y U Y N Y U Y U 7.5 high thick journal high
Sullivan et al., 2020 Y Y Y Y Y U U U Y Y 8.5 high thick journal high
Vreeman et al., 2012 Y Y Y N U P Y Y Y Y 8 High thick journal high
Ward et al., 2018 Y U Y U Y Y N Y Y N 7 high thick journal medium
Key: Y=yes, N=no, U=unclear/unsure, P=partial
Note: The questions refer to those in the JBI-QARI, Table 3
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Table 5. AMSTAR 2 - a critical appraisal tool for systematic reviews. Y=yes, P=partially, N=no, NA=not applicable, PICO=population, 
intervention, comparator group, outcome.
Question Y P N NA
1 Did the research questions and inclusion criteria for the review include the components of PICO? ☐ ☐ ☐ ☐
2 Did the report of the review contain an explicit statement that the review methods were established prior to 
the conduct of the review and did the report justify any significant deviations from the protocol?
☐ ☐ ☐ ☐
3 Did the review authors explain their selection of the study designs for inclusion in the review? ☐ ☐ ☐ ☐
4 Did the review authors use a comprehensive literature search strategy? ☐ ☐ ☐ ☐
5 Did the review authors perform study selection in duplicate? ☐ ☐ ☐ ☐
6 Did the review authors perform data extraction in duplicate? ☐ ☐ ☐ ☐
7 Did the review authors provide a list of excluded studies and justify the exclusions? ☐ ☐ ☐ ☐
8 Did the review authors describe the included studies in adequate detail? ☐ ☐ ☐ ☐
9 Did the review authors use a satisfactory technique for assessing the risk of bias (RoB) in individual studies 
that were included in the review?
☐ ☐ ☐ ☐
10 Did the review authors report on the sources of funding for the studies included in the review? ☐ ☐ ☐ ☐
11 If meta-analysis was performed did the review authors use appropriate methods for statistical combination 
of results?
☐ ☐ ☐ ☐
12 If meta-analysis was performed, did the review authors assess the potential impact of RoB in individual 
studies on the results of the meta-analysis or other evidence synthesis?
☐ ☐ ☐ ☐
13 Did the review authors account for RoB in individual studies when interpreting/ discussing the results of the 
review?
☐ ☐ ☐ ☐
14 Did the review authors provide a satisfactory explanation for, and discussion of, any heterogeneity observed 
in the results of the review?
☐ ☐ ☐ ☐
15 If they performed quantitative synthesis did the review authors carry out an adequate investigation of 
publication bias (small study bias) and discuss its likely impact on the results of the review?
☐ ☐ ☐ ☐
16 Did the review authors report any potential sources of conflict of interest, including any funding they 
received for conducting the review?
☐ ☐ ☐ ☐






































































































































Chilengi, 2009 P P Yes No No No No No No No No N/A N/A Yes Yes Yes
Cohen et al., 2009 Yes Yes Yes Yes Yes Yes Yes Yes Yes No Yes N/A N/A Yes Yes Yes
Embleton et al., 2015  P P Yes No No No No No No Yes No N/A N/A Yes Yes Yes
Ngongo et al., 2012  Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes N/A N/A Yes Yes Yes
Oduwo and Edwards, 
2014
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes N/A N/A Yes Yes Yes
Richards and 
Helmchen, 2013
P P Yes No No No No No No No No N/A N/A Yes Yes Yes
Stunkel and Grady, 
2011
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes N/A N/A Yes Yes Yes 
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paper was analysed, and key details were recorded including 
year of publication, country in which the study was conducted, 
methods used, the phenomenon of interest, and target popu-
lation. Furthermore, note was made of funding sources and 
any potential conflict of interest. Only qualitative data were 
extracted, whatever the type of research method used (qualitative 
or systematic reviews).
Data synthesis
The review followed the principles of a thematic synthesis 
approach as described by Thomas et	al.29,30. This process involved 
the aggregation of findings and categories to generate a set 
of synthesised statements that represented aggregation through 
categorisation of findings related in meaning by all the three 
reviewers (BK, ND, and JS). We followed the three stages out-
lined in thematic synthesis theory: (i) coding text from the 
methods, findings, and discussion sections of the included 
studies line-by-line; (ii) organising free codes into related 
areas to structure descriptive themes to capture meaning; and 
(iii) developing analytical themes31. The themes for synthesis 
were predefined from the research questions that guided the cod-
ing, and then additional themes emerged as the data was exam-
ined. The outcome of coding was verified and discussed by 
BK with ND and JS to check for clarity, consistency and 
understanding. Each study was read several times to ensure 
that all texts relating to provision of care or support to study 
participants were integrated. The concepts were examined for 
similarities and differences and grouped together based on 
shared meanings to create new codes, and then organised into a 
set of descriptive themes32.
Results
The electronic search across all databases yielded a total of 
4,710 references of which 3,469 unique articles remained after 
removal of duplicates, Figure 1. All 3,469 were screened by title 
and abstract. A total of 3,379 articles that did not meet the 
Figure 1. Prisma flow diagram – identification of relevant studies.
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inclusion criteria were removed during screening. Of the 90 
full-text articles screened, 66 were excluded: 20 were opin-
ion or commentary papers, 9 were conducted outside East and 
Southern Africa, 35 reported provision of care that was related 
to the study (not ancillary), and 2 were workshop or meet-
ing reports. The remaining 24 articles met the inclusion criteria 
and were included in the quality assessment.
Characteristics of included studies
All of the studies reported in the review were conducted in 
East and Southern African settings: Kenya (n=6)33–38, Uganda 
(n=2)39,40, Malawi (n=5)41–45, South Africa (n=4)46–49, 
Tanzania (n=1)50, one study (n=1)51 was conducted at mul-
tiple research centres of East and Southern Africa and those 
that focused on RCS in general (n=5)52–56. In total, 16 studies 
were qualitative, four were systematic reviews, three were 
theoretical and one quantitative. Only qualitative data was 
extracted from the quantitative study and used in the analysis. 
Although the search criteria focused on studies published from 
June 2004 to November 2020, 85% of the studies were pub-
lished since 2010, reflecting a more contemporary context. This 
was expected given the fact that the concept of ancillary care in 
medical research has been increasingly recognised as a 
complex ethical challenge particularly where medical research 
is conducted in RCS. The included studies are summarised in 
Table 7.
Key themes
The studies focused on different approaches to ancillary care 
provision (direct medical care, referral, non-medical support); 
researcher motivation for providing ancillary care (inadequate 
health care options, lack of available and accessible basic 
medical services, constraints in resources, vulnerability due to 
socio-economic inequalities); and participation for purpose 
(gaining access to medical care and support, ancillary care 
alternative for standard care offered by the local health care 
system, better medical care). A theme matrix of the included 
studies is summarised in Table 8.
Approaches to ancillary care provision
In total, 14 studies conducted in Kenya (n=5)33,34,36–38, Malawi 
(n=3)41,44,45, South Africa (n=3)46–48, Uganda (n=2)39,40, and 
East and Southern Africa research centres (n=1)51 were 
explicit in mentioning the care and support provided to study 
participants additional to the study related care. Three main 
approaches are reported in the included studies that researchers 
use to address health needs of their participants identified dur-
ing the conduct of research. The type of ancillary care reported 
in these studies ranged from provision of medical care by the 
research team or partners to assisting with referral services 
for participants to access additional care (Table 9).
Direct medical care. Studies that reported researchers pro-
vided health care according to the needs of participants made 
available access to free medical treatment, screening and 
diagnostic services and other services such as counselling. 
Some studies reported that participants felt that they get better 
medical services when they join to participate in medical 
research.
Two studies reported the provision of ancillary care being 
extended to non-research participating individuals includ-
ing partners of volunteers, ineligible to participate volunteers 
following screening, and former volunteers47,51.
Referral. Referral was common for those participating in medi-
cal research to access healthcare services from partners or 
local health care service providers if not provided for by 
researchers. Referral was described to support participating 
individual access to specialised services or services not pro-
vided locally such as diagnostic and screening services or met 
the healthcare costs incurred by participants only during the 
study33,38,40,46,51.
Non-medical support. While most of the studies reported the 
provision of health or medical care to meet participants’ needs, 
there was a range of studies that mentioned non-health related 
support, and some studies provided both including for exam-
ple provision for the tuition for children of parents participating 
in a study or the provision of water and sanitation in households 
and communities where research was conducted34,36,39,42.
Researcher’s motivation for providing ancillary care
Researcher motivations for providing ancillary care referred to 
researchers’ justifications for meeting a particular additional 
need requiring either health care or support services. Ten studies 
explicitly mentioned the reasons researchers took a decision 
to consider providing care and support for their participants’ 
ancillary health needs33,35,36,40,46,47,50–52,54. 
Increased vulnerabilities due to the lower socio-economic sta-
tus of most participants in RCS was a frequently cited reason 
for ancillary care provision33,36,54, justified because individuals 
failed to afford the costs for access to routine or basic medi-
cal care and treatment such as antiretroviral treatment35. Other 
studies reported poor and resource-constrained health care 
demanding for additional mechanisms to address participants 
needs36,40,50,51.
Participation for purpose
Evidence that individuals volunteer to participate in 
medical research to accrue benefits was reported in ten 
studies34,35,39,40,42,44,46–48,52. Although participation is voluntary in 
medical research, participants expect researchers to be clear 
about the benefits whether directly or indirectly adding to their 
study responsibilities. Participants expectations on benefits 
from participating in medical research were reported across 
the majority of the studies. Perceived benefits expected by 
participants were dominated by the opportunity to access 
better quality care unavailable in the local health care 
system38,42,44,45,50,55.
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for providing ancillary 
care
Participation for purpose
1 2 3 1 2 3 1 2 3
Barsdorf et al., 2010 x x
Embleton et al., 2015 x x
Richards and Helmchen, 2013 x
Chou et al., 2007 x x x x
Pratt and Hyder, 2018 x
Ngongo et al., 2012 x x x
Ward et al., 2018 x x x
Chilengi, 2009 x
Kamuya et al., 2013 x x
Ramjee et al., 2010 x x x
Lairumbi et al., 2012 x x x x
Devries et al., 2015 x x x x x
Mtunthama et al., 2008 x x x
Nkosi et al., 2020 x x x
Stunkel and Grady, 2011 x
Mfutso-Bengo et al., 2015 x x x
Vreeman et al., 2012 x x x x
Cohen et al., 2009 x
Gooding et al., 2018 x
Essack et al., 2010 x x
Oduwo and Edwards, 2014 x x
Kamuya et al., 2014 x x
Mfutso-Bengo et al., 2008 x x x
Sullivan et al., 2020 x x x
Key
1 = direct medical 
care 
2 = referral 
3 = non-medical 
support
1 = inadequate health care 
options 
2 = constrained resources 
3 = vulnerability due to 
socio-economic inequalities
1 = gain access to care and 
support 
2 = alternative for standard 
care 
3 = better medical care
Gaining access to better medical care and support was reported 
as one of the direct benefits that most participants expected. 
Additional direct benefits included researchers providing direct 
health care for any problem presented or found in their par-
ticipants, but not as a direct result of participation39,40,42,44,46,52. 
Some studies reported participants expectations beyond direct 
medical care provided by the study, such as for food items, cell 
phone airtime, and baby clothes34,36,47,48. Others thought that 
participants considered provision of ancillary care as an alterna-
tive for standard care offered by the local health care system39, 
for example, participants thinking that effective drugs are always 
available in medical research clinics42 and that any researcher 
Page 14 of 20
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is mistakenly considered as a doctor who would provide 
care for any health problem34.
Discussion
This study describes the practices of ancillary care provision 
to study participants in medical research in East and South-
ern Africa. The results show that reporting on care and support 
provided for the ancillary health needs of study participants in 
RCS remains low, despite growing calls for its implementation 
in medical research9,57–59. For researchers conducting medical 
research in RCS to consider planning for ancillary care, 
as recommended in international ethical guidelines, the 
existing evidence-base is currently insufficient to guide best 
practice. For example, in the commentary to guideline 6 of the 
CIOMS it states that “while	 sponsors	 are	 generally	 not	
obliged	 to	 provide	 healthcare	 services	 beyond	 what	 is	 required	
for	 their	 research,	 it	 is	 morally	 admirable	 to	 do	 so”2, but as 
universal guidelines how relevant are they to contexts with 
underlying poverty or structural inequalities in health care 
access? Should ancillary care be considered as unethical when 
it is really a need among participants and communities in RCS? 
Because it is difficult to establish whether medical research-
ers care about participants’ ancillary care needs, it was hard to 
explore the rationale for decisions on provision of ancil-
lary care, particularly in clinical trials and observational stud-
ies. According to Haire60, it could be that the possible reasons 
why medical researchers fail to provide ancillary care to their 
participants include funders’ or sponsors’ stringent rules over 
research funds. The systematic review and meta-synthesis 
undertaken here points toward some key considerations in 
relation to optimising the evidence on the ethics of ancillary 
care in research especially where it is conducted in RCS.
The findings of this study, consistent with the findings of other 
studies conducted in RCS, reveal that given the numerous 
health challenges faced by individual volunteers who partici-
pate in medical research, it may be obvious that researchers 
bear some responsibilities (not all) for the well-being of their 
participants61. The evidence has shown that participants in 
research conducted in RCS are likely to be socioeconomi-
cally vulnerable and face particular barriers to access healthcare 
services62. This inequality in health care access presents medi-
cal researchers in RCS with a need to provide or consider ancil-
lary care for their participants as a direct benefit. The possible 
levels of ancillary care reported in the findings of this review 
are similar to what Dickert and Wandler58 suggested which 
include: providing diagnostic information, making referrals for 
care, providing treatment, or paying for treatment. Ancillary 
needs of participants were documented in at least some of the 
included studies in this review, and researchers’ responsive-
ness to them was reported as justification for the provision of 
additional care. A cross-cutting theme in our synthesis was 
the tension between what researchers can provide as ancillary 
care for participants’ unmet health needs and the obligations 
linked to ethics of conducting medical research. However, 
it has proven difficult to establish strict rules as to what 
levels of ancillary care is universally required of researchers 
working in RCS13,58.
While some contend that the provision of ancillary care can be 
perceived as either structural coercion or undue inducement 
for study participants or communities because of the health-
care disparities in RCS16,18,63, we argue that applying ethical 
guidelines makes this a requirement. Applying the concepts of 
coercion and undue influence are inadequate in determining 
whether or not ancillary care is unethical in medical research. 
We agree with JA Fisher16 in asserting that these terms (coer-
cion and undue influence) only serve as a rational approach to 
ethics, one that ignores the social and economic contexts of 
research and instead places those domains outside the needs 
of participants. When considering the arguments advanced by 
others on medical researchers’ obligations, we contend that 
it is ethical for researchers to demonstrate responsiveness to 
the ancillary needs of individual participants or communities 
by offering care or support if they have the capacity to do so13. 
Both L Belsky and HS Richardson1 and MW Merritt11 have also 
suggested that the duty to address the health needs of study 
participants must be well anticipated and planned for dur-
ing the planning of research studies, and funds specifically 
budgeted to provide ancillary care. In this review, however, 
it is unclear to what extent authors of the included studies 
included plans to provide for the ancillary health needs. That 
said, there are key questions concerning the impact this has on 
ethical research practice in RCS.
Notwithstanding the concerns that different authors raise about 
ancillary care, the findings support the theory that the ancil-
lary care model has the potential to promote individual’s 
participation in medical research1. Careful consideration 
of what participants expect from participating in medical 
research, as reported in the included studies, ancillary care 
can only be regarded as a benefit for individual volunteers to 
participate35,42,47,50. Although most of the included studies that 
reported ancillary care provision to study participants did 
not mention any ethical conflicts encountered, Lairumbi and 
colleagues35 suggested that since ancillary care conflates the 
benefits in research participation to those of clinical care – it 
may lead to errors in ethical judgement. While identifying varia-
tions in ancillary care practices across studies can indicate ways 
to strengthen medical research design, there is a debate 
over how much ancillary care is needed to be ethical48, and 
how to make standardised research design responsive when 
approaches from different studies vary.
In order to develop and maintain trust and commitment of par-
ticipants to the research, findings in this review revealed that 
researchers felt the need to demonstrate an understanding of 
participant health needs and be responsive to them46,51,52,54. 
Special consideration on strategies that can improve con-
ceptualisation of ancillary care are recommended to balance 
study related demands with ethical conduct of research and 
ancillary care obligations. Furthermore, medical research should 
be conducted with proper clinical and ethical oversight, and 
participants should be treated in a way that minimizes risks 
and maximises (feasible) benefits to their well-being.
Additionally, our findings highlight the importance of research-
ers seeking a balance between taking into consideration the 
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immense health burdens their participants face, while also 
ensuring that study regulations are upheld. Providing ancillary 
care in medical research is a critical issue to consider in RCS, 
but whereas provision of any care unrelated to the study may 
appear to be in question, this study reveals that such care is 
often critical. It must be noted that if additional care is given to 
participants through the study, would it qualify as reciprocity? 
In that specific case, who defines what benefit is in the context 
of RCS? If the community defines school fees as a benefit to 
them and researchers give it to them, should that be considered 
unethical?
This review is not without limitations. As discussed above, 
the provision of ancillary care is inconsistently reported in 
most of the biomedical research studies (observational or 
clinical trials). Moreover, due to limited reporting of ancillary 
care in biomedical research in RCS, we were unable to relate 
provision of ancillary care with guidelines from funding institu-
tions. Also, because of the limited research in this area, some 
of the results presented within this review are based on single 
studies rather than the compilation of several studies. To aid clar-
ity when presenting a description of the results of this review, 
we have summarised the volume of evidence supporting key 
themes drawn, Table 8.
Conclusion
This systematic review and meta-synthesis aimed to understand 
the current practices of ancillary care provision by research-
ers conducting medical research in East and Southern Africa. 
While several studies have documented ancillary care being an 
ethical obligation for researchers conducting medical research 
in RCS, this, to our knowledge, is the first systematic review 
and meta-synthesis to assess the reporting of practices in 
East and Southern Africa. Understanding these current prac-
tices could help steer guidelines in the direction that meets 
the broader needs of ancillary care ethics in medical research. 
This review has shown that, factors influencing ancillary care 
decisions, participants expectation from participating in medical 
research, and the ethical basis of conducting medical 
research in settings coupled with competing health challenges 
may explain the current practices of ancillary care in RCS. While 
the specifics of the issues that researchers face are likely to 
vary depending on the type of research and the context in which 
that research is being conducted, we recommend that appro-
priate ancillary care is also a key requirement to strengthen 
research practice and for the long-term sustainability of research 
programmes in RCS. The ethical challenges that must be 
addressed in medical research in RCS, such as those related to 
making provisions for ancillary care to study participants 
during research, are rarely clearly described. We highlight the 
importance of developing adaptable ethics guidelines for medi-
cal researchers in RCS to consider provision of ancillary care 
to their participants, and the need for these ethical guide-
lines to be accounted for in the conduct of medical research 
that aim to enhance quality of life in this population.
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